Drug Master Files for: Cipla Ltd
✉ Email this page to a colleague
Cipla Ltd Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 10642 | A | II | 12/30/1993 | CIPLA LTD | ETOPOSIDE USP |
| 10710 | I | II | 2/7/1994 | CIPLA LTD | ACYCLOVIR |
| 10858 | I | II | 4/11/1994 | CIPLA LTD | MITOXANTRONE HYDROCHLORIDE |
| 11271 | I | II | 12/30/1994 | CIPLA LTD | MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN KURKUMBH, INDIA. |
| 11449 | A | II | 4/17/1995 | CIPLA LTD | FELODIPINE USP |
| 11524 | I | II | 5/24/1995 | CIPLA LTD | FLUCONAZOLE USP |
| 11811 | A | II | 1/15/1996 | CIPLA LTD | NORFLOXACIN USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
